Monthly Archives: August 2024

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Norethisterone (Noriday®) 350microgram tablets MSN/2024/088 Tier 2 – medium impact Date of issue: 22nd August 2024 Norethisterone (Noriday®) 350microgram tablets will be out of stock from late August 2024 until early December 2024. Desogestrel 75microgram tablets remain available and can support [...]

The post Medicine Supply Notification: Norethisterone (Noriday® ) 350microgram tablets appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Naltrexone 50mg tablets MSN/2024/087 Tier 2 – medium impact Date of issue: 22nd August 2024 Naltrexone 50mg tablets (Accord) are in limited supply until early September 2024 and then out of stock until late October 2024. Naltrexone (Adepend®) 50mg tablets (AOP [...]

The post Medicine Supply Notification: Naltrexone 50mg tablets appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Methylphenidate prolonged-release tablets MSN/2024/086 Tier 3 high impact Date of issue: 22nd August 2024 Methylphenidate prolonged-release tablet brands are in limited supply and intermittent regional supply disruptions are expected to continue until October 2024. Lisdexamfetamine (Elvanse®, Elvanse Adult®) capsules remain available [...]

The post Medicine Supply Notification: Methylphenidate prolonged-release tablets appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 1 August 2024) has been published and includes articles on: Yellow Card Biobank: call to contribute to study of genetic links to side effects Letters and medicine recalls sent to healthcare professionals in July 2024. To see the latest MHRA [...]

The post MHRA Drug Safety Update: August 2024 appeared first on Community Pharmacy England.